These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 3983334)

  • 21. Attention deficit hyperactivity disorder, chronic tic disorder, and methylphenidate.
    Gadow KD; Sverd J
    Adv Neurol; 2006; 99():197-207. PubMed ID: 16536367
    [No Abstract]   [Full Text] [Related]  

  • 22. Pharmacokinetics of a guanfacine extended-release formulation in children and adolescents with attention-deficit-hyperactivity disorder.
    Boellner SW; Pennick M; Fiske K; Lyne A; Shojaei A
    Pharmacotherapy; 2007 Sep; 27(9):1253-62. PubMed ID: 17723079
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Attention deficit/hyperactivity disorder].
    Kanbayashi Y
    Ryoikibetsu Shokogun Shirizu; 2003; (40):5-9. PubMed ID: 14626051
    [No Abstract]   [Full Text] [Related]  

  • 24. Sudden death in children treated with a tricyclic antidepressant.
    Med Lett Drugs Ther; 1990 Jun; 32(819):53. PubMed ID: 2342435
    [No Abstract]   [Full Text] [Related]  

  • 25. Rates of adherence to pharmacological treatment among children and adolescents with attention deficit hyperactivity disorder.
    Ibrahim el SR
    Hum Psychopharmacol; 2002 Jul; 17(5):225-31. PubMed ID: 12404679
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Methylphenidate (Ritalin) treatment in attention deficit hyperactivity disorder].
    Shalev R; Gross-Tsur V
    Harefuah; 1997 May; 132(9):672-5. PubMed ID: 9225587
    [No Abstract]   [Full Text] [Related]  

  • 27. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF; Miller A; Fine S
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bipolar disorder and attention-deficit/hyperactivity disorder in children and adolescents.
    Giedd JN
    J Clin Psychiatry; 2000; 61 Suppl 9():31-4. PubMed ID: 10826658
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Atomoxetine in the treatment of attention deficit hyperactivity disorder.
    Kratochvil CJ; Vaughan BS; Daughton JM; Mayfield-Jorgensen ML; Burke WJ
    Expert Rev Neurother; 2004 Jul; 4(4):601-11. PubMed ID: 15853579
    [TBL] [Abstract][Full Text] [Related]  

  • 30. School observations of children with attention-deficit hyperactivity disorder and comorbid tic disorder: effects of methylphenidate treatment.
    Gadow KD; Nolan E; Sprafkin J; Sverd J
    J Dev Behav Pediatr; 1995 Jun; 16(3):167-76. PubMed ID: 7560119
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The nature of the relationship between attention-deficit/hyperactivity disorder and substance use.
    Wilens TE
    J Clin Psychiatry; 2007; 68 Suppl 11():4-8. PubMed ID: 18307375
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modafinil improves symptoms of attention-deficit/hyperactivity disorder across subtypes in children and adolescents.
    Biederman J; Pliszka SR
    J Pediatr; 2008 Mar; 152(3):394-9. PubMed ID: 18280848
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Resolved: cardiac arrhythmias make desipramine an unacceptable choice in children.
    Werry JS; Biederman J; Thisted R; Greenhill L; Ryan N
    J Am Acad Child Adolesc Psychiatry; 1995 Sep; 34(9):1239-45; discussion 1245-8. PubMed ID: 7559320
    [No Abstract]   [Full Text] [Related]  

  • 34. Adult attention deficit hyperactivity disorder and desipramine.
    Magee R; Maier D; Reesal RT
    Can J Psychiatry; 1992 Mar; 37(2):148-9. PubMed ID: 1562962
    [No Abstract]   [Full Text] [Related]  

  • 35. Attention-deficit hyperactivity disorder; AIDS in children and adolescents.
    Alger I
    Hosp Community Psychiatry; 1989 Dec; 40(12):1222-3. PubMed ID: 2480324
    [No Abstract]   [Full Text] [Related]  

  • 36. [The hyperkinetic syndrome and its relation to the syndrome of attention deficit disorder].
    Lerman P
    Harefuah; 1986 Mar; 110(6):298-300. PubMed ID: 3525349
    [No Abstract]   [Full Text] [Related]  

  • 37. Anhedonic ejaculation with desipramine.
    Rosenbaum JF; Pollack MH
    Int J Psychiatry Med; 1988; 18(1):85-8. PubMed ID: 3397227
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fluoxetine inhibits desipramine metabolism.
    Wilens TE; Biederman J; Baldessarini RJ; McDermott SP; Puopolo PR; Flood JG
    Arch Gen Psychiatry; 1992 Sep; 49(9):752. PubMed ID: 1514882
    [No Abstract]   [Full Text] [Related]  

  • 39. The drug-placebo response curve: a new method for assessing drug effects in clinical trials.
    Faraone SV; Biederman J; Spencer TJ; Wilens TE
    J Clin Psychopharmacol; 2000 Dec; 20(6):673-9. PubMed ID: 11106140
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sudden death in children receiving Norpramin: a review of three reported cases and commentary.
    Riddle MA; Nelson JC; Kleinman CS; Rasmusson A; Leckman JF; King RA; Cohen DJ
    J Am Acad Child Adolesc Psychiatry; 1991 Jan; 30(1):104-8. PubMed ID: 2005044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.